NWPF

News ArchivesRead News

Acupuncture Slows Parkinson’s Disease - New Discovery

Tuesday December 18, 2012

www.healthcmi.com - New research reveals how acupuncture protects the brain in areas damaged by Parkinson’s disease. Scientists at the World Health Organization Collaborating Center for Traditional Medicine have discovered two acupuncture points that prevent the breakdown of an important brain protecting enzyme, tyrosine hydroxylase. This enzyme helps the body to create L-DOPA, an important dopamine precursor and drug used in the treatment of Parkinson’s disease. It is now known that acupuncture prevents decreases of the L-DOPA creating enzyme in the thalamic portions of the brain thereby improving the motor function that is destroyed by Parkinson’s disease.

Loss of dopamine neurons in the substantia nigra portion of the brain is a key pathology in Parkinson’s disease and tardive dyskinesia. The World Health Organization (WHO) scientists have discovered that acupuncture inhibits decreases of tyrosine hydroxylase in nigrostriatal dopaminergic neurons thereby protecting dopamine neuron levels in the substantia nigra portion of the brain. Depletion of these neurons leads to Parkinson’s disease and acupuncture stimulation of acupoints GB34 and LV3 prevents depletion by sustaining tyrosine hydroxylase levels.

About the Acupoints
Acupuncture point LV3 has been historically used to treat tremors such as those associated with Parkinson’s disease. It is located on the dorsum of the foot in the fossa between the first and second metatarsal bones. Its traditional classifications in Chinese medicine theory include: shu-stream point, source point, earth point, heavenly star point. Traditional functions of the point include: move Liver Qi, quell Liver Yang and wind, nourish the Liver, regulate menstruation, stop pain and clear the head and eyes. Common applications for the use of LV3 (Great Rushing, Taichong) include the treatment of menstrual disorders, headaches, dizziness, epilepsy, tremors, high blood pressure, insomnia and blurry vision.

Acupuncture point GB34 has been historically used to treat a variety of conditions including hemiplegia, total paralysis of the arm, leg and trunk on one side of the body. Common usage by licensed acupuncturists includes the treatment of tendon, ligament and joint disorders. Traditional classifications for this acupoint are: He-Sea, earth point, influential point of the tendons, heavenly star point. GB34 is indicated for the treatment of pain related conditions such as sciatica, hip pain, joint pain, muscle pain, tendon pain and knee pain.

According to Chinese medicine theory, both acupuncture points harmonize the Shaoyang channel. This makes both points well suited to treat disorders associated with tremors and other symptoms associated with Parkinson’s disease. Further research is required to determine whether or not other acupoints that harmonize the Shaoyang channel prevent decreases of tyrosine hydroxylase in the brain.

Recent News

Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s